loadpatents
name:-0.022117137908936
name:-0.013144969940186
name:-0.010895967483521
KEANEY; Gregg F. Patent Filings

KEANEY; Gregg F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KEANEY; Gregg F..The latest application filed is for "pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same".

Company Profile
11.20.29
  • KEANEY; Gregg F. - Lexington MA
  • Keaney; Gregg F. - Belmont MA
  • KEANEY; Gregg F. - Blemont MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions Of A Selective C-kit Kinase Inhibitor And Methods For Making And Using Same
App 20220184045 - KEANEY; Gregg F. ;   et al.
2022-06-16
Crystalline Forms Of A Selective C-kit Kinase Inhibitor
App 20220056026 - Keaney; Gregg F. ;   et al.
2022-02-24
Heteroaromatic Nmda Receptor Modulators And Uses Thereof
App 20210403474 - Anderson; David R. ;   et al.
2021-12-30
Crystalline Forms Of Potassium Channel Modulators
App 20210395229 - Keaney; Gregg F. ;   et al.
2021-12-23
Potassium Channel Modulators
App 20210380571 - Amrutkar; Dipak Vasantrao ;   et al.
2021-12-09
Certain Pladienolide Compounds And Methods Of Use
App 20210163456 - KEANEY; Gregg F. ;   et al.
2021-06-03
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use
App 20200361915 - Keaney; Gregg F. ;   et al.
2020-11-19
Potassium channel modulators
Grant 10,774,064 - Eriksen , et al. Sept
2020-09-15
Heteroaromatic NMDA receptor modulators and uses thereof
Grant 10,752,633 - Anderson , et al. A
2020-08-25
Crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pi- ridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-- 1-carboxylate and methods of use thereof
Grant 10,745,387 - Keaney , et al. A
2020-08-18
Potassium channel modulators
Grant 10,717,728 - Amrutkar , et al.
2020-07-21
Heteroaromatic Nmda Receptor Modulators And Uses Thereof
App 20200131190 - Anderson; David R. ;   et al.
2020-04-30
Heteroaromatic NMDA receptor modulators and uses thereof
Grant 10,584,131 - Anderson , et al.
2020-03-10
Heteroaromatic Nmda Receptor Modulators And Uses Thereof
App 20200039987 - Anderson; David R. ;   et al.
2020-02-06
Potassium Channel Modulators
App 20190352293 - Amrutkar; Dipak Vasantrao ;   et al.
2019-11-21
Potassium Channel Modulators
App 20190218200 - Eriksen; Birgitte Langer ;   et al.
2019-07-18
Potassium channel modulators
Grant 10,351,553 - Amrutkar , et al. July 16, 2
2019-07-16
Solid State Form Of Pladienolide Pyridine Compounds And Methods Of Use
App 20190100513 - Keaney; Gregg F. ;   et al.
2019-04-04
Potassium Channel Modulators
App 20180215746 - Amrutkar; Dipak Vasantrao ;   et al.
2018-08-02
Methods For The Treatment Of Tremors By Positive Modulation Of Sk Channels
App 20180207138 - Amrutkar; Dipak Vasantrao ;   et al.
2018-07-26
Potassium channel modulators
Grant 9,975,886 - Amrutkar , et al. May 22, 2
2018-05-22
Enzymatic transamination of cyclopamine analogs
Grant 9,879,293 - Austad , et al. January 30, 2
2018-01-30
Potassium Channel Modulators
App 20170355708 - Jefson; Martin R. ;   et al.
2017-12-14
Tetrazolones As Inhibitors Of Fatty Acid Synthase
App 20170119734 - Bahadoor; Adilah ;   et al.
2017-05-04
Pladienolide pyridine compounds and methods of use
Grant 9,481,669 - Keaney , et al. November 1, 2
2016-11-01
Enzymatic Transamination Of Cyclopamine Analogs
App 20160177354 - Austad; Brian C. ;   et al.
2016-06-23
Tetrazolones as inhibitors of fatty acid synthase
Grant 9,346,769 - Bahadoor , et al. May 24, 2
2016-05-24
Pladienolide Pyridine Compounds and Methods of Use
App 20150329528 - Keaney; Gregg F. ;   et al.
2015-11-19
Enzymatic Transamination of Cyclopamine Analogs
App 20140371456 - Austad; Brian C. ;   et al.
2014-12-18
Enzymatic transamination of cyclopamine analogs
Grant 8,703,448 - Austad , et al. April 22, 2
2014-04-22
Tetrazolones As Inhibitors Of Fatty Acid Synthase
App 20140079667 - BAHADOOR; Adilah ;   et al.
2014-03-20
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
Grant 8,609,706 - Castro , et al. December 17, 2
2013-12-17
Tetrazolones as inhibitors of fatty acid synthase
Grant 8,546,432 - Bahadoor , et al. October 1, 2
2013-10-01
Triazoles As Inhibitors Of Fatty Acid Synthase
App 20130243727 - BAHADOOR; Adilah ;   et al.
2013-09-19
Triazoles as inhibitors of fatty acid synthase
Grant 8,450,350 - Bahadoor , et al. May 28, 2
2013-05-28
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
App 20130131063 - Castro; Alfredo C. ;   et al.
2013-05-23
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
Grant 8,178,690 - Castro , et al. May 15, 2
2012-05-15
Enzymatic Transamination of Cyclopamine Analogs
App 20120083607 - Austad; Brian c. ;   et al.
2012-04-05
Triazoles As Inhibitors Of Fatty Acid Synthase
App 20110274654 - BAHADOOR; Adilah ;   et al.
2011-11-10
Tetrazolones As Inhibitors Of Fatty Acid Synthase
App 20110274655 - BAHADOOR; Adilah ;   et al.
2011-11-10
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
App 20110213145 - Castro; Alfredo C. ;   et al.
2011-09-01
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
Grant 7,928,244 - Castro , et al. April 19, 2
2011-04-19
Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
App 20080114167 - CASTRO; Alfredo C. ;   et al.
2008-05-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed